Curvebeam Announces FDA 510(K) Clearance For HiRise Weight Bearing Ct System For The Entire Lower Extremity

CurveBeam announced the HiRise, its weight bearing CT (WBCT) imaging system for the entire lower extremity, has received FDA 510(K) clearance.

CurveBeam is the leader in weight bearing CT imaging for the orthopedic extremities. Only CurveBeam systems offer a wide patient platform that lets patients stand naturally on both feet during a scan.

CurveBeam’s HiRise can scan anywhere along the lower extremity from the hip & pelvis to the feet. WBCT imaging of the hip & pelvis is a novel application not previously available in any system.

“CurveBeam’s mission is to be responsive to crucial but unmet diagnostic needs of the specialties it serves, and introduction of the HiRise device is the latest transformational step in that direction,” said CurveBeam President & CEO Arun Singh. “This system literally achieves new heights in point of care advanced orthopedic imaging.”

Two HiRise systems were installed for investigational studies prior to FDA clearance at University of Iowa Carver School of Medicine’s Department of Orthopedics and Rehabilitation in Iowa City, IA and at Tennessee Orthopaedic Clinics (TOC) in Knoxville, TN.

The HiRise gantry tilts for upper extremity imaging and supine lower leg imaging.

Researchers at University of Iowa are using the HiRise for multiple research studies, including examining hip dysplasia in functional position and evaluating wrist injuries in gymnasts.

“The HiRise promises to revolutionize our biomechanical understanding of the entire lower extremity the same way previous generations of CurveBeam’s weight bearing CT systems enabled better investigation into the foot, ankle and knee,” said Dr. Cesar de Cesar Netto, MD, PhD, Assistant Professor of Orthopedics and Rehabilitation at University of Iowa.

CurveBeam’s systems utilize cone beam CT technology and are designed for the orthopedic point-of-care setting. The HiRise plugs into a standard wall outlet, requires minimal shielding, and is easy to operate.

CurveBeam announced CE Marking for the HiRise in October.

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More